
Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. St. Jude touts Euro approval for updated CRM implants
Medical device giant St. Jude Medical lands CE Mark approval in the European Union for upgraded versions of its Assura cardiac rhythm management implants.
2. Cardiovascular Systems closes enrollment in Diamondback trial
Cardiovascular Systems closes enrollment in a clinical trial of its Diamondback 360 Orbital atherectomy device for clearing calcium from clogged coronary arteries.
1. Smith & Nephew’s $782M Healthpoint buyout raises eyebrows
Smith & Nephew announces a $782 million acquisition for wound care products maker Healthpoint Biotherapeutics, a move that generated mixed reactions for analysts.